CompletedNot applicableNCT00383305
CoolCap Trial, Treatment of Perinatal Hypoxic-Ischemic Encephalopathy
Studying Neonatal hypoxic and ischemic brain injury
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Olympic Medical
- Principal Investigator
- Peter D Gluckman, M.D., M.DThe Liggins Institute, University of Auckland; Auckland, New Zealand
- Intervention
- Cool-Cap(device)
- Enrollment
- 235 enrolled
- Eligibility
- All sexes
- Timeline
- 1999 – 2003
Study locations (27)
- Arkansas Children's Hospital, Little Rock, Arkansas, United States
- Children's Hospital and Research Center at Oakland, Oakland, California, United States
- University of California San Diego Medical Center (Hillcrest), San Diego, California, United States
- University of California San Francisco Children's Hospital, San Francisco, California, United States
- Children's Hospital of Denver, Denver, Colorado, United States
- Children's Memorial Hospital / Prentice Women's Hospital, Chicago, Illinois, United States
- University of Illinois at Chicago Medical Center, Chicago, Illinois, United States
- Johns Hopkins University, Baltimore, Maryland, United States
- University of Michigan Medical Center - Mott Children's Hospital, Ann Arbor, Michigan, United States
- Children's Hospital and Clinics of Minneapolis, Minneapolis, Minnesota, United States
- Schneider Children's Hospital, New Hyde Park, New York, United States
- Children's Hospital of new York - Presbyterian (Columbia University), New York, New York, United States
- Golisano Children's Hospital at Strong, Rochester, New York, United States
- Duke University Medical Center, Durham, North Carolina, United States
- Wake Forest University Baptist Medical Center, Winston-Salem, North Carolina, United States
- +12 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00383305 on ClinicalTrials.govOther trials for Neonatal hypoxic and ischemic brain injury
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT07464938New Tools and Predictive Markers in the Prognosis of Hypoxic-ischemic Encephalopathy Following Cardiac ArrestCliniques universitaires Saint-Luc- Université Catholique de Louvain
- ENROLLING BY INVITATIONNCT07264166Intranasal AAV9-PHP.eB Gene Therapy in Cerebral Palsy (CP) & Hypoxic Ischemic Encephalopathy (HIE)Healing Hope International
- RECRUITINGNCT07393620Predictive Value of aEEG and Cerebral Oxygenation on Neurological Outcomes in Newborns With Mild Hypoxic-Ischemic EncephalopathyUludag University
- RECRUITINGNANCT07527104Autologous Bone Marrow Mononuclear Cell Transplantation Combined With Rehabilitation in Children With Sequelae of Hypoxic-Ischemic Encephalopathy or Intracranial HemorrhageNational Children's Hospital, Vietnam
- ENROLLING BY INVITATIONPHASE1NCT06429007A Safety and Feasibility Trial Protocol of Metformin in Infants After Perinatal Brain InjuryBoston Children's Hospital
- RECRUITINGNANCT07555652Therapeutic Hypothermia for Neonatal Hypoxic-Ischemic Encephalopathy in VietnamNational Children's Hospital, Vietnam
- RECRUITINGNANCT06762795The HIEnome Study: Genome Sequencing for Perinatal HIEBaylor College of Medicine
- RECRUITINGNCT07136636Speech of Kids After Neonatal EncephalopathySemmelweis University
See all trials for Neonatal hypoxic and ischemic brain injury →